UnknownPhase 1NCT00769613
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Milton S. Hershey Medical Center
- Principal Investigator
- Kenneth G. Lucas, MDMilton S. Hershey Medical Center
- Intervention
- cytomegalovirus IE-1-specific cytotoxic T lymphocytes(biological)
- Enrollment
- 20 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2008
Study locations (1)
- Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00769613 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.